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ABSTRACT
Granulocyte-macrophage  colony  stimulating  factor  (GM-CSF)  is  a  cytokine  that 
stimulates the production of leukocytes as part of an immune response.  The role that 
GM-CSF plays in the immune system is reliant on its tightly controlled expression, 
both temporally and spatially.  The overall aim of this thesis was to investigate the 
factors that contribute to the correct temporal and spatial expression of  GM-CSF in 
immune cells.
It was found that while GM-CSF expression can be stimulated in murine T cells but 
not  B cells,  key transcription  factors  involved in  GM-CSF gene  expression were 
present  in  both  cell  types,  leading  to  the  hypothesis  that  epigenetic  mechanisms 
underlie  this  differential  response.   In  support  of  this,  differences  in  DNA 
methylation,  histone  modifications  and  the  presence  of  chromatin  remodelling 
proteins were detected at the GM-CSF promoter between the two cell types.
DNA methylation levels were higher at a CpG dinucleotide in the GM-CSF promoter 
in  T  compared  to  B  cell  lines,  and  DNA methylation  of  the  GM-CSF promoter 
blocked expression from a reporter plasmid. Demethylation of the promoter was not 
sufficient to enable  GM-CSF gene expression in B cells,  although it  increased its 
expression  in  T  cells.   The  effect  of  removing  the  CpG  dinucleotide,  which  is 
contained  in  an  Sp1  transcription  factor  binding  site,  was  also  examined.   In  a 
transiently  transfected reporter  model,  removal  of the Sp1 site  resulted in loss of 
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promoter activity. However, in a stably integrated transgene model, the Sp1 mutant 
promoter exhibited an increased response to stimulation.  The differential response of 
the promoter mutant between the transient and stably transfected models suggests 
that the chromatin environment of the gene plays an important role in transcriptional 
regulation.
To further examine the importance of chromatin in GM-CSF gene regulation, histone 
modifications were examined at the GM-CSF promoter in T and B cell lines.  Several 
key differences were observed.  In T cells, acetylation of histone H3 was increased at 
the GM-CSF promoter relative to B cells.  Increasing promoter acetylation levels by 
treatment  with  the  histone  deacetylase  inhibitor  Trichostatin  A  (TSA)  facilitated 
expression of GM-CSF in the B cell lines in response to stimulation.  Furthermore, 
TSA treatment in combination with DNA demethylation had a synergistic effect on 
GM-CSF expression in both T and B cells.  In contrast to histone acetylation, histone 
H3 lysine 27 trimethylation was lower at the GM-CSF promoter in T cells relative to 
B cells.  Finally, the chromatin remodelling protein Brg1, which is known to interact 
with acetylated histones, was present at the  GM-CSF promoter in T cells at higher 
levels than in B cells.
These data suggest that enrichment of histone H3 acetylation and Brg1 and decreased 
H3K27Me3 contribute to the establishment of a ‘permissive’ chromatin environment 
at the GM-CSF promoter in T cells, which is not present at the promoter in B cells. 
A ‘permissive’ chromatin environment can be established at the GM-CSF promoter 
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in B cells following treatment with TSA, which increases histone acetylation. This 
allows remodelling of the promoter  chromatin and subsequent  gene expression in 
response  to  immune  signals.   However,  this  induced  ‘permissive’  state  is  not 
maintained.  Following  removal  of  the  inducing  stimulus  in  A20  B  cells,  the 
chromatin is reset to its original ‘repressive’ state and the  GM-CSF gene becomes 
unresponsive to subsequent stimulation.
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